| CWIAX | ECDIX | CWIAX / ECDIX | |
| Total Expense Ratio | 0.75 | 1.92 | 39% |
| Annual Report Gross Expense Ratio | 0.75 | 1.92 | 39% |
| Fund Existence | 25 years | 23 years | - |
| Gain YTD | 17.028 | 14.250 | 119% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 156B | 846M | 18,440% |
| Annual Yield % from dividends | 1.35 | 2.67 | 51% |
| Returns for 1 year | 17.18 | 26.04 | 66% |
| Returns for 3 years | 54.75 | 65.27 | 84% |
| Returns for 5 years | 39.81 | 46.69 | 85% |
| Returns for 10 years | 115.53 | 132.56 | 87% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MAPPX | 25.86 | 0.56 | +2.21% |
| Morgan Stanley Inst Advantage A | |||
| NMANX | 15.30 | 0.16 | +1.06% |
| Neuberger Mid Cap Growth Inv | |||
| HSMBX | 47.18 | 0.38 | +0.81% |
| Horizon Multi-Factor Small/Mid Cap Adv | |||
| JVACX | 42.18 | 0.22 | +0.52% |
| JPMorgan Value Advantage C | |||
| RYMGX | 62.12 | 0.31 | +0.50% |
| Rydex S&P MidCap 400 Pure Growth A | |||